DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic Leukemia

NCT03265717 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

BIOLOGICAL: INVAC-1

Sponsor

Invectys

Collaborators

[object Object]